Filing Analysis
Peraso Inc. announced retroactive salary increases for its top three executive officers, effective July 1, 2026. The increases apply to the CEO, CFO, and COO.
🚩 Red Flags
- Retroactive pay increases can sometimes be viewed as a way to distribute cash to insiders outside of standard performance cycles, though the 5% amount is relatively modest.
📋 Key Facts
- Compensation Committee approved a 5% increase in annual base salary for all named executive officers.
- Effective date of salary increases: July 1, 2026.
- CEO Ronald Glibbery's salary increased from $400,000 to $420,000.
- CFO James Sullivan's salary increased from $305,000 to $320,250.
- COO Bradley Lynch's salary increased from $275,000 to $288,750.
- The salary increases will also affect the calculation of target annual bonuses and severance benefits for these officers.
Peraso Inc. filed an 8-K to announce its financial results for the three months ended June 30, 2026. The filing includes a press release and provides reconciliations for non-GAAP financial measures such as Adjusted EBITDA.
🚩 Red Flags
- Continued reliance on non-GAAP metrics (Adjusted EBITDA) which exclude significant recurring costs like stock-based compensation.
📋 Key Facts
- Report date: August 11, 2026
- Reporting period: Three months ended June 30, 2026
- The company uses non-GAAP measures including Adjusted EBITDA to assess performance.
- Non-GAAP adjustments include stock-based compensation and changes in the fair value of warrant liabilities.
Peraso Inc. announced that Director Daniel Lewis will not stand for re-election at the upcoming 2026 annual meeting of stockholders due to his planned retirement.
📋 Key Facts
- Daniel Lewis provided written notice of his intention to retire.
- His current term expires at the Company's 2026 annual meeting of stockholders.
- The departure is not due to any disagreement with the Company regarding operations, policies, or practices.
Peraso Inc. received a deficiency notice from Nasdaq because its common stock failed to maintain the minimum $1.00 bid price requirement for 30 consecutive business days ending July 20, 2026. The company has been granted a 180-day compliance period until January 19, 2027.
🚩 Red Flags
- Delisting notice from Nasdaq (Rule 5550(a)(2)).
- Potential for mandatory reverse stock split to regain compliance.
- Stock price has been consistently below the $1.00 threshold.
📋 Key Facts
- Nasdaq deficiency notice received on July 21, 2026.
- Failure to meet the $1 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- Compliance period granted until January 19, 2027 (180 days).
- To regain compliance, stock must close at or above $1.00 for at least 10 consecutive business days during the period.
- The company may need to effect a reverse stock split to meet requirements if it seeks a second 180-day extension.
Peraso Inc. entered into a Letter Agreement with Roth Principal Investments, LLC to adjust the purchase price discount for certain stock purchases to 5.0% of the Volume Weighted Average Price (VWAP). This modification pertains to an existing Common Stock Purchase Agreement dated June 30, 2026.
🚩 Red Flags
- Use of equity financing via purchase agreements (often indicative of liquidity needs)
- Discounted stock purchases for institutional investors can lead to dilution of existing shareholders
📋 Key Facts
- Date of agreement: July 10, 2026
- Counterparty: Roth Principal Investments, LLC
- Adjustment: Purchase price discount for Pre-Market and Post-Market Purchases set to 5.0% of VWAP
- The modification relates to a previously disclosed Common Stock Purchase Agreement dated June 30, 2026.
Peraso Inc. entered into a Common Stock Purchase Agreement with Roth Principal Investments, LLC for the potential sale of up to $25,000,000 in newly issued common stock over 36 months.
🚩 Red Flags
- Highly dilutive financing structure: The company can issue up to $25M in new shares at significant discounts to market price.
- At-the-market (ATM) style mechanism with Roth Principal Investments often associated with micro-cap liquidity needs and potential downward pressure on stock price due to continuous selling/dilution.
📋 Key Facts
- Agreement dated June 30, 2026, with Roth Principal Investments, LLC.
- Potential equity raise of up to $25,000,000 via new common stock issuances.
- The company has sole discretion over the timing and amount of sales (Equity Line of Credit/At-the-Market style).
- Purchase prices include discounts to VWAP: 3.0% for Market Open/Intraday purchases and 6.0% for Pre-Market/Post-Market purchases.
- Includes a Registration Rights Agreement for the resale of shares by Roth Principal Investments.
- Subject to a Nasdaq Exchange Cap (19.99%) unless specific price thresholds or shareholder approval are met.
Peraso Inc. announced the appointment of Cees Links to the Board and Audit Committee following the retirement of Ian McWalter. The filing also details results from the 2025 Annual Meeting, including the approval of an amendment to the 2019 Stock Incentive Plan.
🚩 Red Flags
- New director Cees Links previously served as CEO of SuperLight Photonics B.V., a company that declared bankruptcy in September 2025.
📋 Key Facts
- Cees Links appointed to the Board and Audit Committee effective immediately following the Annual Meeting.
- Ian McWalter retired from the Board at the expiration of his term during the Annual Meeting.
- Stockholders approved an amendment to the 2019 Stock Incentive Plan to increase reserved shares by 1,000,000.
- The Board removed limits on the number of shares subject to equity awards for non-employee directors.
- Weinberg & Company, P.A. was re-ratified as the independent registered public accounting firm for FY2025.
- Annual Meeting quorum represented approximately 38.7% of outstanding voting shares.
Peraso Inc. has entered into a third amendment to extend the expiration date of its outstanding Series C Warrants from December 5, 2025, to January 7, 2026.
🚩 Red Flags
- Repeated extensions of warrant expiration dates suggest difficulty in meeting original terms or managing dilution/capitalization needs.
- Potential for significant future dilution upon exercise of the 1.29M shares at $1.61 per share.
📋 Key Facts
- The extension applies to Series C Warrants to purchase up to 1,293,650 shares of common stock.
- The exercise price for the warrants is $1.61 per share.
- This marks the third amendment to extend the expiration date (previously extended from May 6, 2025, to August 4, 2025, and then to December 5, 2025).
- The shares are registered under Form S-3 (File No. 333-283573) declared effective on December 10, 2024.
Peraso Inc. announced the retirement of director Ian McWalter and filed a prospectus supplement to increase its At-the-Market (ATM) offering capacity by $3.15 million.
🚩 Red Flags
- Continued use of At-the-Market (ATM) offerings suggests ongoing need for liquidity/working capital.
- The company has already utilized over $4 million in previous ATM sales, indicating a pattern of equity dilution to fund operations.
📋 Key Facts
- Director Ian McWalter will not stand for re-election at the 2025 annual meeting due to planned retirement.
- The company is increasing the maximum number of shares issuable under its ATM Sales Agreement with Ladenburg Thalmann & Co. Inc. by up to $3,150,000.
- Approximately $4,095,176 in shares have already been sold under the existing Sales Agreement.
- The offering is being conducted via a Form S-3 registration statement originally filed on July 12, 2024.
Peraso Inc. filed an 8-K to announce its financial results for the three and nine months ended September 30, 2025. The filing primarily serves as a vehicle to furnish the press release containing these results and provides detailed reconciliations of non-GAAP financial measures.
🚩 Red Flags
- Continued use of non-GAAP metrics (Adjusted EBITDA) which exclude significant recurring items like stock-based compensation.
- Historical context of employee layoffs and severance costs indicates past volatility in operating expenses.
📋 Key Facts
- Reported financial results for the three and nine months ended September 30, 2025.
- Management utilizes Adjusted EBITDA as a key non-GAAP metric, excluding stock-based compensation, amortization, severance, warrant liability changes, interest, depreciation, and taxes.
- Intangible assets from the 2021 Peraso Tech acquisition were fully amortized as of December 31, 2024.
- Severance costs related to the 2023 workforce reductions were fully paid during the quarter ended September 30, 2025.
Peraso Inc. entered into a mutual confidentiality agreement with Mobix Labs, Inc. on October 30, 2025. This agreement is related to the Company's ongoing review of strategic alternatives.
🚩 Red Flags
- Mention of 'review of strategic alternatives' often signals potential M&A activity, sale of the company, or restructuring.
📋 Key Facts
- Entered into a mutual confidentiality agreement with Mobix Labs, Inc. on October 30, 2025.
- The agreement includes customary terms including a mutual 12-month standstill and non-solicitation provisions.
- The context of the agreement is the Company's 'ongoing review of strategic alternatives'.
Peraso Inc. has filed a prospectus supplement to increase the maximum aggregate amount of shares issuable under its existing At-the-Market (ATM) offering agreement with Ladenburg Thalmann & Co. Inc. This increases the available capacity for equity sales by up to $1,750,000.
🚩 Red Flags
- Potential dilution of existing shareholders through the issuance of new common stock.
- Continuous use of ATM offerings often indicates a need for immediate working capital to fund operations, which can be a sign of cash burn concerns in micro-cap companies.
📋 Key Facts
- Company is increasing the maximum number of shares issuable under an existing At-the-Market (ATM) Offering Agreement.
- The increase is for an aggregate amount of up to $1,750,000 in new shares.
- Prior sales under the same agreement have already reached a gross sales price of $2,686,953.
- The offering will be conducted pursuant to the existing Form S-3 registration statement (File No. 333-280798) declared effective on July 22, 2024.
- Ladenburg Thalmann & Co. Inc. serves as the agent for the sales agreement.
Peraso Inc. provided an update on its outstanding securities as of October 3, 2025. The filing details a significant amount of potential dilution through various warrants, options, and restricted stock units.
🚩 Red Flags
- Extreme potential dilution: The number of issuable shares (approx. 11M+) significantly exceeds the current outstanding common stock (approx. 7.5M).
- Low-cost warrant exercises: Multiple recent series of warrants (Series D, E) have strike prices ($1.25 - $1.61) well below the historical option exercise price ($3.38), suggesting heavy downward pressure on share price or significant dilution to existing holders.
📋 Key Facts
- As of October 3, 2025, there were 7,579,223 shares of common stock outstanding.
- Total issuable shares via warrants/options/RSUs exceed 11 million shares, representing significant potential dilution relative to current outstanding shares.
- Series D Warrants (dated Nov 6, 2024) represent a large block of 2,246,030 issuable shares at $1.61 per share.
- Series E Warrants (dated Sept 12, 2025) account for 952,380 shares at $1.25 per share.
- Stock options have a weighted average exercise price of $3.38 per share.
Peraso Inc. announced on September 22, 2025, that it has regained compliance with Nasdaq's minimum bid price requirement following a notification from the Nasdaq Listing Qualifications Department.
🚩 Red Flags
- Previous non-compliance with Nasdaq's minimum bid price requirement indicates past stock price volatility or weakness.
📋 Key Facts
- Received notification from Nasdaq Listing Qualifications Department on September 19, 2025.
- Company has successfully regained compliance with Nasdaq Listing Rule 5550(a)(2) regarding minimum bid price requirements.
- The announcement was made via a press release filed as Exhibit 99.1.
Peraso Inc. entered into an inducement agreement with a warrant holder to facilitate the exercise of existing Series C warrants at a significant discount ($1.18 vs $1.61). In exchange, the company is issuing new Series E warrants and providing registration rights, resulting in approximately $1.1 million in gross proceeds for working capital.
🚩 Red Flags
- Significant warrant dilution: The issuance of new Series E warrants at a lower exercise price ($1.25) than the original Series C ($1.61) indicates distressed financing terms.
- Down-round characteristics: Reducing the exercise price to induce cash is often a sign of liquidity pressure.
- Cashless exercise provision: The holder has the right to receive shares instead of cash if a registration statement is not effective, which can lead to rapid dilution.
📋 Key Facts
- Existing Series C warrants will be exercised at a reduced price of $1.18 per share (original price was $1.61).
- Company to issue new Series E common stock purchase warrants to the holder with an exercise price of $1.25.
- Expected gross proceeds from warrant exercise: approximately $1.1 million.
- Ladenburg Thalmann & Co. Inc. acting as exclusive placement agent; 9% cash fee plus expense reimbursement up to $45,000.
- The holder is subject to a leak-out provision (max 20% of daily volume) until 15 days after Sept 11, unless stock price ≥ $1.50.
- Company agreed not to issue other equity or file new registration statements for 20 days.
Peraso Inc. has entered a phase of exploratory discussions with Mobix Labs, Inc., following an unsolicited proposal to acquire the Company via cash and stock. The company is currently undergoing a strategic review process.
🚩 Red Flags
- The acquisition proposal is 'unsolicited,' which can sometimes indicate a defensive posture by the target company's board.
- The terms of the deal (cash/stock ratio and total amount) remain undetermined, creating significant uncertainty for shareholders.
📋 Key Facts
- Mobix Labs, Inc. issued two letters (dated Sept 4 and Sept 5, 2025) containing a revised unsolicited acquisition proposal.
- The proposed transaction would involve both cash and stock consideration in an undetermined amount.
- Peraso has invited Mobix Labs to a limited exploratory call to understand their intentions.
- Discussions are intended to occur without the sharing of material non-public information (MNPI) or formal confidentiality agreements.
Peraso Inc. received a notice from Nasdaq stating the company is in violation of the minimum $1.00 bid price requirement. The company has been granted a 180-day grace period to regain compliance, which expires on March 4, 2026.
🚩 Red Flags
- Delisting notice from Nasdaq.
- Potential requirement for a reverse stock split to cure deficiency if price remains low.
- Failure to maintain minimum bid price is a sign of significant market cap erosion or loss of investor confidence.
📋 Key Facts
- Nasdaq issued a deficiency notice on September 5, 2025.
- The violation is based on the closing bid price being below $1.00 for 30 consecutive business days ending September 4, 2025.
- Compliance period: 180 calendar days (until March 4, 2026).
- To regain compliance, the stock must close at or above $1.00 for at least ten consecutive business days during the grace period.
Peraso Inc. issued a press release providing an update on its ongoing strategic review process and developments regarding an unsolicited non-binding proposal from Mobix Labs, Inc.
🚩 Red Flags
- Unsolicited non-binding proposals often indicate a period of corporate uncertainty and potential volatility in share price.
📋 Key Facts
- The filing relates to an ongoing strategic review process previously disclosed on June 27, 2025.
- Updates concern an unsolicited non-binding proposal received from Mobix Labs, Inc.
- The company is currently evaluating developments related to this proposal.
Peraso Inc. filed an 8-K to announce its financial results for the three and six months ended June 30, 2025. The filing primarily serves as a vehicle to furnish a press release containing GAAP and non-GAAP financial measures.
🚩 Red Flags
- Continued use of non-GAAP metrics to mask operational performance (standard for micro-caps but requires scrutiny).
📋 Key Facts
- Financial results announced for the periods ending June 30, 2025.
- Management utilizes Adjusted EBITDA as a key non-GAAP metric, which excludes stock-based compensation, amortization, severance costs, warrant liability fair value changes, interest, depreciation, and taxes.
- Intangible assets from the December 2021 Peraso Tech acquisition were fully amortized as of December 31, 2024.
- Severance amounts related to a November 2023 layoff were fully paid in July 2025.
Peraso Inc. has entered into a second amendment to extend the expiration date of its outstanding Series C Warrants from August 4, 2025, to December 5, 2025. This extension prevents the immediate expiration of warrants covering up to 2,246,030 shares of common stock.
🚩 Red Flags
- Repeated extensions of warrant expiration dates may indicate difficulty in meeting milestones or liquidity constraints required for exercise.
- Potential future dilution of existing shareholders upon the exercise of 2.2M+ shares at $1.61/share.
📋 Key Facts
- The Company entered into a second amendment to its Series C Warrants on August 4, 2025.
- The new expiration date for the warrants is December 5, 2025, at 5:00 p.m. NYC time.
- The Series C Warrants allow for the purchase of up to an aggregate of 2,246,030 shares of common stock.
- The exercise price for these warrants is $1.61 per share.
- This is the second extension; the expiration was previously moved from May 6, 2025, to August 4, 2025.
Peraso Inc. announced on July 11, 2025, that its Board of Directors has authorized the exploration of strategic alternatives. This typically indicates the company is considering a sale, merger, restructuring, or other major corporate transaction.
🚩 Red Flags
- Exploration of 'strategic alternatives' is often a precursor to distressed M&A, liquidation, or significant dilutive restructuring in micro-cap companies.
📋 Key Facts
- Board of Directors authorized the exploration of strategic alternatives on July 11, 2025.
- The announcement was made via a press release filed as Exhibit 99.1.
- Company is listed on Nasdaq under ticker PRSO.
Peraso Inc. has confirmed receipt of an unsolicited, non-binding acquisition proposal from an unidentified party as of June 27, 2025.
📋 Key Facts
- The company received an unsolicited, non-binding acquisition proposal on June 27, 2025.
- The proposal is currently classified as 'non-binding'.
- The announcement was made via a press release (Exhibit 99.1).
Peraso Inc. announced on June 20, 2025, that it has regained compliance with the Nasdaq minimum bid price requirement (Rule 5550(a)(2)) following a notification letter received on June 18, 2025.
🚩 Red Flags
- Previous non-compliance with Nasdaq's minimum bid price requirement (implied by the regaining of compliance).
📋 Key Facts
- Received notification from Nasdaq Listing Qualifications Department on June 18, 2025.
- Regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- The company remains listed on the Nasdaq Stock Market LLC.
Peraso Inc. issued a press release announcing its financial results for the three months ended March 31, 2025. The filing primarily focuses on the disclosure of non-GAAP financial measures and reconciliations used to evaluate operational performance.
🚩 Red Flags
- Ongoing severance payments/costs through July 2025 indicating recent restructuring activity.
📋 Key Facts
- Reported financial results for the quarter ending March 31, 2025.
- Management utilizes various non-GAAP measures including Adjusted EBITDA, excluding stock-based compensation, amortization of intangibles, severance costs, and changes in fair value of warrant liabilities.
- Intangible assets from the December 2021 acquisition of Peraso Technologies Inc. were fully amortized as of December 31, 2024.
- Severance charges related to a November 2023 layoff are expected to be paid through July 2025.
Peraso Inc. has entered into an amendment to extend the expiration date of its outstanding Series C Warrants from May 6, 2025, to August 4, 2025. The warrants allow holders to purchase up to 2,246,030 shares at an exercise price of $1.61 per share.
🚩 Red Flags
- Potential dilution for existing shareholders upon exercise of the 2.2M+ warrants.
- The extension suggests that warrant holders may not have intended to exercise prior to the original May expiration, potentially indicating a lack of immediate liquidity or desire to convert into equity.
📋 Key Facts
- Extension of Series C Warrants expiration date from May 6, 2025, to August 4, 2025.
- Total aggregate shares issuable upon exercise: 2,246,030 shares of common stock.
- Exercise price per share: $1.61.
- Warrants were originally issued on November 6, 2024, as part of inducement offer letter agreements.
Peraso Inc. received a deficiency notice from Nasdaq because its common stock closed below the $1 minimum bid price requirement for 30 consecutive business days ending April 3, 2025. The company has been granted a 180-day compliance period to regain listing status.
🚩 Red Flags
- Delisting notice from Nasdaq
- Potential requirement for a reverse stock split to maintain listing
- Sustained period (30 days) of trading below the $1 threshold
📋 Key Facts
- Nasdaq issued a deficiency notice on April 4, 2025, regarding Nasdaq Listing Rule 5550(a)(2).
- The deficiency is due to the stock closing below $1.00 for 30 consecutive business days ending April 3, 2025.
- The company has a 180-day period (until October 1, 2025) to regain compliance by maintaining a $1 minimum bid price for at least ten consecutive business days.
- If the deficiency is not cured within 180 days, the company may be eligible for an additional 180-day extension if it intends to cure via a reverse stock split.
Peraso Inc. filed an 8-K to announce its financial results for the three and twelve months ended December 31, 2024. The filing primarily serves as a vehicle to furnish the quarterly press release and provide reconciliations for non-GAAP financial measures.
🚩 Red Flags
- Ongoing severance payments related to previous layoffs (expected through Oct 2025) indicate recent restructuring/cost-cutting measures.
- Continued use of non-GAAP adjustments for stock-based compensation and warrant liability fair value changes, which can mask underlying cash flow volatility.
📋 Key Facts
- Reported financial results for the three and twelve months ended December 31, 2024.
- Management utilizes Adjusted EBITDA as a key non-GAAP metric, excluding stock-based compensation, amortization, severance, warrant liability changes, interest, depreciation, and taxes.
- Severance charges related to employee layoffs from November 2023 are expected to be paid through October 2025.
- The company continues to exclude amortization of intangibles stemming from the December 2021 acquisition of Peraso Technologies Inc.
Peraso Inc. announced the granting of stock option awards to its top three executives (CEO, CFO, and COO) on February 11, 2025.
🚩 Red Flags
- Low exercise price ($0.7776) may indicate significant dilution or a low current market price relative to historical highs.
📋 Key Facts
- Grant date: February 11, 2025
- Recipients: Ronald Glibbery (CEO), James Sullivan (CFO), and Bradley Lynch (COO)
- Award amount: 100,000 stock options per executive
- Exercise price: $0.7776 per share
- Vesting schedule: Equal monthly installments over 36 months starting March 2025
- Expiration date: February 11, 2035
Peraso Inc. held its 2024 annual meeting of stockholders on December 20, 2024. Stockholders approved the election of five directors, the ratification of Weinberg & Company, P.A. as independent auditors, and an amendment to increase shares reserved under the 2019 Stock Incentive Plan.
📋 Key Facts
- Annual Meeting held on December 20, 2024, with a quorum representing approximately 45.3% of voting power.
- Five directors (Ronald Glibbery, Daniel Lewis, Ian McWalter, Andreas Melder, and Robert Y. Newell) were elected to serve until the next annual meeting.
- Proposal 2 was approved: Ratification of Weinberg & Company, P.A. as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Proposal 3 was approved: Amendment to increase shares reserved under the Amended and Restated 2019 Stock Incentive Plan by 1,500,000 shares.
Peraso Inc. has filed a prospectus supplement to increase the maximum aggregate amount of shares issuable under its 'At The Market' (ATM) offering agreement with Ladenburg Thalmann & Co. Inc.
🚩 Red Flags
- Use of an 'At The Market' (ATM) offering is often used by micro-cap companies to raise working capital, which can lead to immediate dilution for existing shareholders.
- The need to increase the ATM capacity suggests a continuous requirement for liquidity.
📋 Key Facts
- Increased the maximum number of shares issuable under the Sales Agreement by up to $2,693,527.
- The increase excludes $169,215 in shares already sold to date.
- The offering is conducted via a Form S-3 registration statement originally filed on July 12, 2024.
- Ladenburg Thalmann & Co. Inc. serves as the agent for the Sales Agreement.
Peraso Inc. notified Nasdaq that its stockholders' equity fell below the $2.5 million minimum requirement as of September 30, 2024. However, following a warrant inducement offering, the company believes it has regained compliance.
🚩 Red Flags
- Delisting notice/non-compliance with Nasdaq minimum stockholders' equity requirement.
- Significant dilution via warrant inducement (Series C and D warrants issued to existing holders).
- Drastic reduction in exercise price ($2.25 to $1.30) indicates distressed financing terms.
📋 Key Facts
- Stockholders' equity was reported at approximately $2,026,000 as of September 30, 2024, failing Nasdaq's $2.5 million minimum requirement (Rule 5550(b)(1)).
- The company completed a Warrant Inducement Offering which generated net proceeds of approximately $2.6 million.
- Existing Series B warrants were exercised at a reduced price of $1.30 per share (down from the original $2.25).
- In exchange, the company issued new Series C and Series D common stock purchase warrants to the holders.
- The company believes it has regained compliance with the Stockholders' Equity Requirement as of the date of the report.
Peraso Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2024. The filing focuses on the disclosure of GAAP vs. non-GAAP financial measures used to evaluate operational performance.
🚩 Red Flags
- Ongoing severance payments expected through October 2025 indicates recent workforce reductions/restructuring.
📋 Key Facts
- Reporting period: Three and nine months ended September 30, 2024.
- Company is utilizing non-GAAP measures including Adjusted EBITDA.
- Non-GAAP adjustments include stock-based compensation, amortization of intangibles (from Dec 2021 acquisition), severance costs, and changes in fair value of warrant liabilities.
- Severance charges related to a reduction in force are expected to be paid through October 2025.
Peraso Inc. entered into inducement agreements to encourage holders of existing Series B warrants to exercise them at a significant discount ($1.30 vs $2.25). In exchange, the company is issuing new Series C and D warrants, resulting in potential massive dilution for existing shareholders.
🚩 Red Flags
- Significant dilution: The issuance of millions of new warrants at prices below current market value (implied by the discount) heavily dilutes existing equity.
- Desperation capital raise: Using 'inducement letters' to lower exercise prices is often a sign of liquidity pressure and an attempt to prevent warrant expiration/lapse.
- Rapidly approaching expiration: The original warrants expire on November 8, 2024, leaving the company very little time to finalize these terms.
📋 Key Facts
- Existing Series B warrants (expiring Nov 8, 2024) will be exercised at a reduced price of $1.30 per share instead of the original $2.25.
- The company expects to receive approximately $2.9 million in gross proceeds from this exercise.
- New Series C and D warrants will be issued to participating holders, covering an aggregate of 4,492,060 new shares (2,246,030 each).
- The New Warrants have an exercise price of $1.61 per share.
- Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent with various cash and warrant-based fees.
- The company agreed to a 30-day standstill on issuing new common stock or filing new registration statements following Nov 5, 2024.
Peraso Inc. has entered into a second amendment to its Warrant Agency Agreement, extending the expiration date of its outstanding Series B warrants. The extension moves the deadline from October 7, 2024, to November 8, 2024.
🚩 Red Flags
- Repeated extensions: This is the second time the company has extended the expiration of these warrants (previously extended from Aug 8 to Oct 7).
- Potential dilution: The warrants represent a significant number of shares (nearly 4 million) that could be issued at $2.25 per share upon exercise.
📋 Key Facts
- The Company extended the expiration of Series B Warrants (CUSIP 71360T 135) to 5:00 p.m. NYC time on November 8, 2024.
- This is the second amendment to the Warrant Agency Agreement dated February 8, 2024.
- The warrants allow for the purchase of up to 3,974,520 shares of common stock.
- The exercise price per share is $2.25.
- This represents a second extension; the previous expiration date was August 8, 2024.
Peraso Inc. entered into an 'at the market' (ATM) offering agreement with Ladenburg Thalmann & Co. Inc. to sell up to $1,425,000 of common stock. The program allows for flexible issuance of shares at the company's discretion to raise capital.
🚩 Red Flags
- Potential for immediate shareholder dilution through the issuance of new common stock.
- ATM offerings are often used by micro-cap companies to bolster cash runways, which can signal liquidity needs.
📋 Key Facts
- Entered into an At The Market (ATM) Offering Agreement with Ladenburg Thalmann & Co. Inc. on August 30, 2024.
- Aggregate offering price is up to $1,425,000 in common stock.
- Ladenburg will receive a cash commission of 3.0% of aggregate gross sales proceeds.
- Company to reimburse Ladenburg for expenses not to exceed $60,000, plus legal disbursements up to $7,500.
- The offering is conducted under an existing S-3 registration statement filed on July 12, 2024.
Peraso Inc. filed an 8-K to announce its financial results for the three and six months ended June 30, 2024. The filing focuses on the presentation of non-GAAP financial measures used by management to evaluate operational performance.
🚩 Red Flags
- Ongoing severance costs related to previous workforce reductions (impacted 16 employees in Nov 2023).
📋 Key Facts
- Reported financial results for the three and six months ended June 30, 2024.
- Management utilizes Adjusted EBITDA as a key non-GAAP metric, excluding stock-based compensation, amortization, severance, warrant liability changes, interest, depreciation, and taxes.
- The company is continuing to process severance charges related to employee terminations following the November 2023 reductions; these are expected to be paid over the next 13 months.
- Non-GAAP measures exclude amortization of intangibles from the December 2021 acquisition of Peraso Technologies Inc.
Peraso Inc. has amended its Warrant Agency Agreement to extend the expiration date of its outstanding Series B Warrants. The extension moves the deadline from August 8, 2024, to October 7, 2024.
🚩 Red Flags
- Extension of warrant expiration suggests potential difficulty in having holders exercise warrants before the original deadline, possibly due to stock price being below the $2.25 strike price.
- The proximity of the original expiration (August 8) to the filing date indicates a time-sensitive liquidity or capital structure event.
📋 Key Facts
- Series B Warrants allow for the purchase of up to 3,974,520 shares of common stock.
- The exercise price for these warrants is $2.25 per share.
- The expiration date was extended from August 8, 2024, to October 7, 2024.
- The amendment was entered into on August 6, 2024, with Equiniti Trust Company, LLC as the warrant agent.
Peraso Inc. issued a business update and announced unaudited preliminary revenue for the quarter ended June 30, 2024. The filing serves to furnish preliminary financial information via a press release.
🚩 Red Flags
- Preliminary revenue figures are unaudited and may differ materially from final audited results.
📋 Key Facts
- Company released an update on business operations and preliminary revenue for Q2 2024 (ended June 30, 2024).
- The financial results provided are unaudited and subject to change.
- The filing includes a press release as Exhibit 99.1.
Peraso Inc. entered into a private stock purchase agreement on June 11, 2024, with board member Ian McWalter. The company sold 100,000 shares at $1.27 per share to the director for a total of $127,000.
🚩 Red Flags
- Related-party transaction involving a member of the Board of Directors
- Issuance of restricted securities without existing registration rights
📋 Key Facts
- Date of agreement: June 11, 2024
- Counterparty: Ian McWalter (Member of the Company's Board of Directors)
- Number of shares issued: 100,000 common stock shares
- Price per share: $1.27
- Aggregate gross proceeds: $127,000
- Use of proceeds: General corporate purposes, including R&D and working capital
- Securities type: Restricted securities under Rule 144; no registration rights included
Peraso Inc. filed an 8-K to announce its financial results for the three months ended March 31, 2024. The filing includes a press release and provides reconciliations for non-GAAP financial measures used by management.
🚩 Red Flags
- Ongoing volatility in net income/loss due to the re-valuation of warrant liabilities (non-cash but impact GAAP results)
📋 Key Facts
- Report date: May 13, 2024
- Reporting period: Three months ended March 31, 2024
- Management utilizes Adjusted EBITDA as a key non-GAAP measure
- Non-GAAP adjustments include stock-based compensation, amortization of intangibles, and change in fair value of warrant liabilities
- The company continues to re-value warrant liabilities issued in November 2022 and June 2023
Peraso Inc. announced a new non-cancelable purchase order from an existing customer totaling $2.88 million. This order is related to end-of-life (EOL) last-time buys for the company's memory integrated circuit products.
🚩 Red Flags
- Revenue is tied to 'end-of-life' product cycles, suggesting a wind-down of specific product lines rather than new growth in those segments.
📋 Key Facts
- Received an additional purchase order totaling $2.88 million.
- The order is non-cancelable.
- Order pertains to incremental 'last-time buys' due to end-of-life (EOL) programs for memory integrated circuit products.
- Filing date: April 4, 2024.
Peraso Inc. filed an 8-K to announce its financial results for the three and twelve months ended December 31, 2023. The filing primarily serves as a vehicle to furnish a press release containing GAAP and non-GAAP financial measures.
🚩 Red Flags
- Ongoing use of non-GAAP measures to exclude significant items like stock-based compensation and amortization, which management acknowledges are material parts of operating results.
📋 Key Facts
- Announced financial results for the periods ending December 31, 2023.
- Management provided reconciliations for non-GAAP measures including Adjusted EBITDA.
- Disclosed historical context regarding a $9.6 million goodwill impairment charge from Q4 2022.
- Discussed treatment of warrant liabilities issued in November 2022 and June 2023.
Peraso Inc. completed a public offering of common stock and various warrants to fund operations and working capital. The offering included significant dilution through multiple series of warrants (Series A, Series B, pre-funded, and underwriter warrants).
🚩 Red Flags
- Significant potential dilution due to the issuance of multiple warrant series (Series A, Series B, Pre-funded, and Underwriter warrants).
- The use of proceeds is for 'operations and working capital,' which often indicates a need for immediate liquidity to sustain burn rate.
- Warrants have exercise prices ($2.25) that are higher than the current offering price ($2.10), indicating they are out-of-the-money.
📋 Key Facts
- Closed the offering on February 8, 2024.
- Net proceeds from the offering were approximately $3.4 million.
- Offered 480,000 shares of common stock at $2.10 per share (combined with warrants).
- Issued Series A and Series B warrants with an exercise price of $2.25 per share.
- Issued pre-funded warrants with an exercise price of $0.001 per share.
- Underwriter was granted a 45-day option to purchase additional securities, partially exercised on February 7, 2024.
- The company has outstanding 1,346,334 shares of Common Stock and 95,093 exchangeable shares.
Peraso Inc. announced preliminary financial results for the quarter and full year ended December 31, 2023. The company reported an increase in cash position driven by end-of-life memory product proceeds.
🚩 Red Flags
- Low cash position of $1.6 million relative to typical micro-cap operational needs.
- Revenue growth heavily dependent on 'end-of-life' memory products which may not be sustainable.
📋 Key Facts
- Estimated Q4 2023 revenue: $1.6 million to $1.9 million.
- Estimated full year 2023 revenue: $13.6 million to $13.8 million.
- Estimated FY 2023 royalty/other revenue: $0.7 million to $0.9 million.
- Cash and cash equivalents at Dec 31, 2023: ~$1.6 million (up ~$0.9 million from Sept 30, 2023).
- Revenue breakdown for FY 2023: Memory ICs ($8.4M), mmWave ICs ($2.8M), and mmWave antenna modules ($1.7M).
Peraso Inc. announced on January 19, 2024, that it has regained compliance with the Nasdaq minimum bid price requirement (Rule 5550(a)(2)). This follows a previous period of non-compliance regarding its stock price.
🚩 Red Flags
- Historical non-compliance with Nasdaq listing rules indicates past volatility or liquidity issues.
📋 Key Facts
- Received notification from Nasdaq Listing Qualifications Department on January 18, 2024.
- The company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- Compliance was achieved following a period of being below the required minimum bid price.